Bullous systemic lupus erythematosus successfully treated with rituximab. 2019

Christopher D Lowe, and Catherine A Brahe, and Brian Green, and Thomas K Lam, and Jon H Meyerle
Section of Dermatology, Walter Reed National Military Medical Center, Bethesda, Maryland, USA.

Bullous systemic lupus erythematosus (BSLE) is a rare complication of systemic lupus erythematosus (SLE) characterized by cutaneous vesicles and bullae with a primarily neutrophilic infiltrate on histopathology. Bullous SLE is a heterogeneous disease without pathognomonic clinical features, making the diagnosis and differentiation from other blistering diseases challenging. We present the case of a single patient with SLE in whom 3 different clinical appearances of BSLE manifested over 5 years. The cutaneous eruption dramatically improved with rituximab at the initial presentation and continued to respond to rituximab during subsequent flares over the subsequent 5 years.

UI MeSH Term Description Entries
D007155 Immunologic Factors Biologically active substances whose activities affect or play a role in the functioning of the immune system. Biological Response Modifier,Biomodulator,Immune Factor,Immunological Factor,Immunomodulator,Immunomodulators,Biological Response Modifiers,Biomodulators,Factors, Immunologic,Immune Factors,Immunological Factors,Modifiers, Biological Response,Response Modifiers, Biological,Factor, Immune,Factor, Immunological,Factors, Immune,Factors, Immunological,Modifier, Biological Response,Response Modifier, Biological
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069283 Rituximab A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS. CD20 Antibody, Rituximab,GP2013,IDEC-C2B8,IDEC-C2B8 Antibody,Mabthera,Rituxan,IDEC C2B8,IDEC C2B8 Antibody,Rituximab CD20 Antibody
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D012872 Skin Diseases, Vesiculobullous Skin diseases characterized by local or general distributions of blisters. They are classified according to the site and mode of blister formation. Lesions can appear spontaneously or be precipitated by infection, trauma, or sunlight. Etiologies include immunologic and genetic factors. (From Scientific American Medicine, 1990) Bullous Skin Diseases,Pustular Dermatosis, Subcorneal,Skin Diseases, Bullous,Skin Diseases, Vesicular,Sneddon-Wilkinson Disease,Subcorneal Pustular Dermatosis,Vesicular Skin Diseases,Vesiculobullous Skin Diseases,Bullous Dermatoses,Vesiculobullous Dermatoses,Bullous Skin Disease,Dermatoses, Bullous,Dermatoses, Subcorneal Pustular,Dermatoses, Vesiculobullous,Dermatosis, Subcorneal Pustular,Pustular Dermatoses, Subcorneal,Skin Disease, Bullous,Skin Disease, Vesicular,Skin Disease, Vesiculobullous,Sneddon Wilkinson Disease,Subcorneal Pustular Dermatoses,Vesicular Skin Disease,Vesiculobullous Skin Disease
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

Christopher D Lowe, and Catherine A Brahe, and Brian Green, and Thomas K Lam, and Jon H Meyerle
January 2023, Clinical, cosmetic and investigational dermatology,
Christopher D Lowe, and Catherine A Brahe, and Brian Green, and Thomas K Lam, and Jon H Meyerle
November 2019, Lupus,
Christopher D Lowe, and Catherine A Brahe, and Brian Green, and Thomas K Lam, and Jon H Meyerle
March 2011, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases,
Christopher D Lowe, and Catherine A Brahe, and Brian Green, and Thomas K Lam, and Jon H Meyerle
January 2004, Clinical and experimental rheumatology,
Christopher D Lowe, and Catherine A Brahe, and Brian Green, and Thomas K Lam, and Jon H Meyerle
September 2016, QJM : monthly journal of the Association of Physicians,
Christopher D Lowe, and Catherine A Brahe, and Brian Green, and Thomas K Lam, and Jon H Meyerle
September 2023, Cureus,
Christopher D Lowe, and Catherine A Brahe, and Brian Green, and Thomas K Lam, and Jon H Meyerle
July 2020, Reumatismo,
Christopher D Lowe, and Catherine A Brahe, and Brian Green, and Thomas K Lam, and Jon H Meyerle
July 2018, Lupus,
Christopher D Lowe, and Catherine A Brahe, and Brian Green, and Thomas K Lam, and Jon H Meyerle
August 2009, The Australasian journal of dermatology,
Christopher D Lowe, and Catherine A Brahe, and Brian Green, and Thomas K Lam, and Jon H Meyerle
January 2008, Scandinavian journal of rheumatology,
Copied contents to your clipboard!